Stroke patients had 30.4% (median) (range 4.2–71.6%) CD4+CD25+ cells on the day of admission, which did not differ significantly from control values 41.2% (median) (range 5.1–73.7%) (p = 0.7886) (Supplemental Figure S2B). The gene discussed is CD4; the disease is stroke disorder.